Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.46 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.46 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.46 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL460021 | 0.89 | SMN1; SMN2 (0.64) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL27768731 | 0.87 | ALDH1A1 (0.59) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Propionic Acid SCHEMBL29662033 | 0.85 | MAPT (0.52) | FFAR3HDAC2HDAC8SMN1; SMN2HPGD | |
| Butyramide SCHEMBL13733187 | 0.84 | SMN1; SMN2 (0.50) | SMN1; SMN2HPGDL3MBTL1SOAT1CES2 | |
| Butyric Acid SCHEMBL29662016 | 0.84 | PTGER1 (0.49) | HDAC3HDAC1HDAC2HDAC8SMN1; SMN2 | |
| Butyric Acid SCHEMBL3208838 | 0.81 | FFAR3 (0.56) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Naphthalene SCHEMBL7796235 | 0.80 | HDAC3 (0.62) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Fluorene SCHEMBL27386948 | 0.80 | NPC1 (0.56) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL7069607 | 0.80 | FFAR3 (0.68) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butane SCHEMBL15105003 | 0.79 | PTGS2 (0.48) | HDAC2HDAC8SMN1; SMN2HPGDSOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260033519-A1 | STORAGE-STABLE BEVERAGES COMPRISING ANTHOCYANINS | BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIV (US) | 2026-02-05 | — | — | US | claimed |
| WO-2025097045-A1 | COLLOIDAL FOOD BASE COMPOSITIONS COMPRISING MYCELIAL BIOMASS | THE FYNDER GROUP, INC (US) | 2025-05-08 | — | — | WO | claimed |
| US-12281070-B2 | Water soluble antiviral and antimicrobial compound and process for preparation thereof | DEB NILANJAN (IN) | 2025-04-22 | — | — | US | claimed |
| US-11963936-B2 | Method of manufacturing stable emulsions and compositions containing the same | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2024-04-23 | — | — | US | claimed |
| US-20230121754-A1 | WATER SOLUBLE ANTIVIRAL AND ANTIMICROBIAL COMPOUND AND PROCESS FOR PREPARATION THEREOF | DEB NILANJAN (IN) | 2023-04-20 | — | — | US | claimed |
| WO-2022108118-A1 | METHOD FOR PRODUCING SULFIDE-BASED SOLID ELECTROLYTE USING ESTER-BASED ORGANIC SOLVENT, AND SULFIDE-BASED SOLID ELECTROLYTE AND ALL-SOLID-STATE BATTERY MANUFACTURED BY SAID MANUFACTURING METHOD | 한국전자기술연구원 | 2022-05-27 | — | — | WO | claimed |
| WO-2022106908-A1 | WATER SOLUBLE ANTIVIRAL AND ANTIMICROBIAL COMPOUND AND PROCESS FOR PREPARATION THEREOF | DEB NILANJAN (IN) | 2022-05-27 | — | — | WO | claimed |
| US-20220079890-A1 | METHOD OF MANUFACTURING STABLE EMULSIONS AND COMPOSITIONS CONTAINING THE SAME | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2022-03-17 | — | — | US | claimed |
| US-20260033519-A1 | STORAGE-STABLE BEVERAGES COMPRISING ANTHOCYANINS | BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIV (US) | 2026-02-05 | — | — | US | disclosed |
| EP-3850052-B1 | SCREEN WASH | TETROSYL I TEC LTD (GB) | 2025-11-05 | — | — | EP | disclosed |
| US-20250143362-A1 | COLLOIDAL FOOD BASE COMPOSITIONS COMPRISING MYCELIAL BIOMASS | THE FYNDER GROUP INC (US) | 2025-05-08 | — | — | US | disclosed |
| WO-2025097045-A1 | COLLOIDAL FOOD BASE COMPOSITIONS COMPRISING MYCELIAL BIOMASS | THE FYNDER GROUP, INC (US) | 2025-05-08 | — | — | WO | disclosed |
| US-12281070-B2 | Water soluble antiviral and antimicrobial compound and process for preparation thereof | DEB NILANJAN (IN) | 2025-04-22 | — | — | US | disclosed |
| US-12098234-B2 | Stability of polyurethane polyol blends containing halogenated olefin blowing agents | ARKEMA INC. (US) | 2024-09-24 | — | — | US | disclosed |
| US-20230121754-A1 | WATER SOLUBLE ANTIVIRAL AND ANTIMICROBIAL COMPOUND AND PROCESS FOR PREPARATION THEREOF | DEB NILANJAN (IN) | 2023-04-20 | — | — | US | disclosed |
| EP-4059573-A1 | SOLUBILISING AGENTS AND COMPOSITIONS COMPRISING SAME | B&Sens (FR) | 2022-09-21 | — | — | EP | disclosed |
| WO-2022187295-A1 | POLOXAMER COMPOSITIONS AND BEVERAGES | Acid Neutral Alkaline Laboratory (US) | 2022-09-09 | — | — | WO | disclosed |
| WO-2022106908-A1 | WATER SOLUBLE ANTIVIRAL AND ANTIMICROBIAL COMPOUND AND PROCESS FOR PREPARATION THEREOF | DEB NILANJAN (IN) | 2022-05-27 | — | — | WO | disclosed |
| WO-2022108118-A1 | METHOD FOR PRODUCING SULFIDE-BASED SOLID ELECTROLYTE USING ESTER-BASED ORGANIC SOLVENT, AND SULFIDE-BASED SOLID ELECTROLYTE AND ALL-SOLID-STATE BATTERY MANUFACTURED BY SAID MANUFACTURING METHOD | 한국전자기술연구원 | 2022-05-27 | — | — | WO | disclosed |
| US-20220079890-A1 | METHOD OF MANUFACTURING STABLE EMULSIONS AND COMPOSITIONS CONTAINING THE SAME | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2022-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230121754-A1 | WATER SOLUBLE ANTIVIRAL AND ANTIMICROBIAL COMPOUND AND PROCESS FOR PREPARATION THEREOF | ZC3HAV1, SAMHD1, ZC3HAV1L | FFAR3 4142/4885HDAC3 3898/4885HDAC1 3075/4885 |
| US-20260033519-A1 | STORAGE-STABLE BEVERAGES COMPRISING ANTHOCYANINS | SIRT1, SIRT3, CRY1 | FFAR3 1347/4885HDAC3 740/4885HDAC1 988/4885 |
| US-12281070-B2 | Water soluble antiviral and antimicrobial compound and process for preparation thereof | ZC3HAV1, SAMHD1, ZC3HAV1L | FFAR3 4250/4885HDAC3 3652/4885HDAC1 2899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.